BUSINESS● LOWSep 10 · Sep 10, 2026, 1:41 PM
Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks
Yahoo Finance · global
A major shareholder of Novartis is advocating for changes to the company's board following recent drug trial failures. This indicates significant corporate governance pressure within the pharmaceutical giant.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS1h agoZelensky announces visit by Turkish energy companies to UkraineUkrinform [en]BUSINESS1h agoFinancial sector rise in October: AI shift lifts CBOE, crypto rout hits COINSeeking Alpha Tech